Pre-earnings options volume in Tempest Therpeutics is normal with calls leading puts 22:1. Implied volatility suggests the market is anticipating a move near 22.5%, or 23c, after results are released. Median move over the past eight quarters is 6.3%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPST:
- Tempest Therapeutics, Inc. (TPST) Q3 Earnings Cheat Sheet
- Morning Movers: GXO Logistics gains following report of potential sale
- Tempest Therapeutics announces agreement with Roche for amezalpat combo therapy
- Tempest Therapeutics extends limited duration of stockholder rights plan
- Tempest Therapeutics appoints Sheldon Mullins as VP, regulatory affairs